Susceptibility of canine chondrocytes and synoviocytes to antibiotic cytotoxicity in vitro. 2021

Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Colorado.

OBJECTIVE To evaluate relative cytotoxicity of antibiotics to normal canine joint tissues in vitro. METHODS Experimental in vitro study. METHODS Chondrocytes and synoviocytes (three dogs); cartilage explants (three dogs); six dogs total. METHODS Chondrocytes and synoviocytes from normal femoropatellar joints of three dogs were plated on 24-well plates (50 000 cells/cm2 , triplicate, 48 hours) and exposed to antibiotics (ampicillin sulbactam, vancomycin, cefazolin, ceftazidime, amikacin, enrofloxacin; 0.39-25 mg/mL, 24 hours). Viability was assessed by using trypan blue dye exclusion. Antibiotic concentrations at which 50% cell death occurred (half-maximal inhibitory concentration) were determined to rank antibiotics for relative cytotoxicity. Occurrence of caspase-3 expression after antibiotic exposure was assessed as an indication of apoptosis induction. Cartilage explants from three different dogs were minced and exposed to antibiotics (amikacin, ceftazidime, cefazolin, enrofloxacin; 5 mg/mL, 72 hours). Live/dead staining was performed, and fluorescence was visualized by using confocal microscopy. Percentage of live vs dead cells was quantitated. RESULTS Viability of chondrocytes and synoviocytes decreased with increasing antibiotic concentrations. Half-maximal inhibitory concentrations were determined for synoviocytes (vancomycin 13.77, ampicillin sulbactam 3.07, amikacin 2.26, ceftazidime 1.62, cefazolin 1.48, enrofloxacin 1.25 mg/mL) and chondrocytes (vancomycin 8.65, ampicillin sulbactam 8.63, ceftazidime 3.16, amikacin 2.74, cefazolin 1.67, enrofloxacin 0.78 mg/mL). Caspase-3 expression was upregulated, providing evidence that apoptotic pathways were active in cell death. CONCLUSIONS Half-maximal inhibitory concentration data provided evidence of lower toxicity of vancomycin and ampicillin sulbactam to joint tissues in vitro. CONCLUSIONS These results provide evidence to justify future in vitro work with osteoarthritic joint tissues and in vivo clinical trials to evaluate safety and efficacy of intra-articular antibiotics to treat dogs with septic arthritis.

UI MeSH Term Description Entries
D008297 Male Males
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D002356 Cartilage A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE. Cartilages
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000070918 Synoviocytes Cells on the luminal surface of the SYNOVIAL MEMBRANE. Type A synoviocytes are MACROPHAGES responsible for waste removal from the joint cavity. Fibroblast-like type B synoviocytes are involved in production of joint matrix constituents (e.g., HYALURONAN; COLLAGEN; and FIBRONECTIN). Synoviocyte
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D019902 Chondrocytes Polymorphic cells that form cartilage. Chondroblasts,Chondroblast,Chondrocyte

Related Publications

Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
March 1998, American journal of veterinary research,
Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
March 2012, Archivos de la Sociedad Espanola de Oftalmologia,
Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
September 2008, American journal of veterinary research,
Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
December 2015, American journal of orthopedics (Belle Mead, N.J.),
Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
February 2000, Veterinary microbiology,
Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
June 1984, Arthritis and rheumatism,
Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
November 2012, Journal of biomedical materials research. Part B, Applied biomaterials,
Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
April 1989, Mikrobiyoloji bulteni,
Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
June 1977, Antimicrobial agents and chemotherapy,
Robert J Newman, and Lyndah Chow, and Laurie R Goodrich, and Nicolaas E Lambrechts, and Steven W Dow, and Lynn M Pezzanite
April 2011, Veterinary microbiology,
Copied contents to your clipboard!